$STRR
STAR EQUITY HOLDINGS, INC.

2013 Q2 Form 10-Q Financial Statement

#000070738813000039 Filed on August 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $12.89M $12.71M
YoY Change 1.42% -10.8%
Cost Of Revenue $9.097M $9.029M
YoY Change 0.75% -11.96%
Gross Profit $3.793M $3.681M
YoY Change 3.04% -7.86%
Gross Profit Margin 29.43% 28.96%
Selling, General & Admin $3.580M $3.482M
YoY Change 2.81% -0.03%
% of Gross Profit 94.38% 94.59%
Research & Development $177.0K $1.047M
YoY Change -83.09% 46.64%
% of Gross Profit 4.67% 28.44%
Depreciation & Amortization $479.0K $547.0K
YoY Change -12.43% -39.09%
% of Gross Profit 12.63% 14.86%
Operating Expenses $4.425M $4.587M
YoY Change -3.53% 7.17%
Operating Profit -$632.0K -$906.0K
YoY Change -30.24% 219.01%
Interest Expense $4.000K $1.000K
YoY Change 300.0% -98.57%
% of Operating Profit
Other Income/Expense, Net $12.00K $15.00K
YoY Change -20.0% -74.14%
Pretax Income -$620.0K -$890.0K
YoY Change -30.34% 286.96%
Income Tax -$4.000K $0.00
% Of Pretax Income
Net Earnings -$616.0K -$891.0K
YoY Change -30.86% 292.51%
Net Earnings / Revenue -4.78% -7.01%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03 -$461.1K
COMMON SHARES
Basic Shares Outstanding 19.03M shares 19.32M shares
Diluted Shares Outstanding 19.03M shares 19.32M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.20M $28.50M
YoY Change -22.11% -8.36%
Cash & Equivalents $12.95M $19.04M
Short-Term Investments $9.200M $9.500M
Other Short-Term Assets $596.0K $778.0K
YoY Change -23.39% -2.75%
Inventory $4.693M $6.247M
Prepaid Expenses
Receivables $6.412M $6.883M
Other Receivables $0.00 $0.00
Total Short-Term Assets $34.12M $42.64M
YoY Change -19.96% -7.52%
LONG-TERM ASSETS
Property, Plant & Equipment $4.469M $5.031M
YoY Change -11.17% -14.73%
Goodwill $184.0K $184.0K
YoY Change 0.0%
Intangibles $461.0K $341.0K
YoY Change 35.19%
Long-Term Investments
YoY Change
Other Assets $82.00K
YoY Change
Total Long-Term Assets $5.196M $5.556M
YoY Change -6.48% -17.07%
TOTAL ASSETS
Total Short-Term Assets $34.12M $42.64M
Total Long-Term Assets $5.196M $5.556M
Total Assets $39.32M $48.19M
YoY Change -18.41% -8.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.816M $1.927M
YoY Change -5.76% -16.22%
Accrued Expenses $2.700M $5.000M
YoY Change -46.0% 11.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.195M $8.804M
YoY Change -6.92% -3.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $295.0K $100.0K
YoY Change 195.0% 0.0%
Total Long-Term Liabilities $295.0K $100.0K
YoY Change 195.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.195M $8.804M
Total Long-Term Liabilities $295.0K $100.0K
Total Liabilities $8.490M $8.917M
YoY Change -4.79% -3.08%
SHAREHOLDERS EQUITY
Retained Earnings -$121.2M -$115.4M
YoY Change 5.03%
Common Stock $2.000K $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.121M $1.655M
YoY Change 209.43% 59.29%
Treasury Stock Shares 2.334M shares 854.9K shares
Shareholders Equity $30.83M $39.27M
YoY Change
Total Liabilities & Shareholders Equity $39.32M $48.19M
YoY Change -18.41% -8.73%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$616.0K -$891.0K
YoY Change -30.86% 292.51%
Depreciation, Depletion And Amortization $479.0K $547.0K
YoY Change -12.43% -39.09%
Cash From Operating Activities -$390.0K -$70.00K
YoY Change 457.14% -108.43%
INVESTING ACTIVITIES
Capital Expenditures -$320.0K -$210.0K
YoY Change 52.38% -30.0%
Acquisitions
YoY Change
Other Investing Activities $920.0K -$4.200M
YoY Change -121.9% -67.16%
Cash From Investing Activities $610.0K -$4.420M
YoY Change -113.8% -66.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.800M -260.0K
YoY Change 976.92% -750.0%
NET CHANGE
Cash From Operating Activities -390.0K -70.00K
Cash From Investing Activities 610.0K -4.420M
Cash From Financing Activities -2.800M -260.0K
Net Change In Cash -2.580M -4.750M
YoY Change -45.68% -61.13%
FREE CASH FLOW
Cash From Operating Activities -$390.0K -$70.00K
Capital Expenditures -$320.0K -$210.0K
Free Cash Flow -$70.00K $140.0K
YoY Change -150.0% -87.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
157142000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1816000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1546000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6329000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6412000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-56000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-99000 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22015000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21301000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
156634000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
136000 USD
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
123000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
479000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
472000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
438000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
399000 shares
CY2013Q2 us-gaap Assets
Assets
39319000 USD
CY2012Q4 us-gaap Assets
Assets
44909000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
34123000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
39387000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
7679000 USD
CY2013Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
9230000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12948000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19514000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24039000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19043000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6566000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4996000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18194323 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19144448 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19144448 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18194323 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-635000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3093000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2198000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-933000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9097000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17826000 USD
CY2012Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9029000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18327000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
4442000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3822000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
2121000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1918000 USD
CY2012Q2 us-gaap Cost Of Services
CostOfServices
6908000 USD
CY2013Q2 us-gaap Cost Of Services
CostOfServices
7179000 USD
us-gaap Cost Of Services
CostOfServices
14004000 USD
us-gaap Cost Of Services
CostOfServices
13885000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1849000 USD
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1655000 USD
us-gaap Depreciation
Depreciation
849000 USD
us-gaap Depreciation
Depreciation
991000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
972000 USD
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
479000 USD
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
547000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1127000 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2364000 USD
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2536000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
38000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4673000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2571000 USD
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1811000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4075000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
184000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
184000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
3793000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
3681000 USD
us-gaap Gross Profit
GrossProfit
7353000 USD
us-gaap Gross Profit
GrossProfit
6610000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
270000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
597000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
129000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
581000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-183000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-194000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
172000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
16000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
343000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-393000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-409000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-53000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-25000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-77000 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-933000 USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
461000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
584000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
4000 USD
us-gaap Interest Expense
InterestExpense
5000 USD
us-gaap Interest Expense
InterestExpense
1000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
1000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1861000 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1696000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
7544000 USD
CY2013Q2 us-gaap Inventory Gross
InventoryGross
7600000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
4979000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
4693000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2522000 USD
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2886000 USD
CY2013Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2907000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2565000 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3018000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3161000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
39000 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
16000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
54000 USD
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
28000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
8490000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
8460000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39319000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44909000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8195000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8284000 USD
CY2013Q2 us-gaap Loss Contingency Settlement Agreement Consideration1
LossContingencySettlementAgreementConsideration1
385000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Company</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Digirad Corporation (&#8220;Digirad&#8221;), a Delaware corporation, is one of the largest national providers of in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals and imaging centers through our Digirad Imaging Solutions (&#8220;DIS&#8221;) segment. Through DIS, we provide in-office imaging services to physicians, offering certified personnel, required licensure, an imaging system and other support and supplies for the performance of nuclear and ultrasound imaging procedures under the supervision of our physician customers. DIS' physician customers enter into service contracts for imaging services generally delivered on a per-day basis. We also sell medical diagnostic imaging systems including solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provide service on the products we sell through our Diagnostic Imaging segment. These </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments, DIS and Diagnostic Imaging, are collectively referred to herein as the &#8220;Company.&#8221; </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements include the operations of both segments. Intercompany accounts and transactions are accounted for at cost and have been eliminated in consolidation. All our long-lived assets are located in the United States and substantially all of our revenues arise from sales activity in the United States. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements included in this Form 10-Q have been prepared in accordance with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) instructions for Quarterly Reports on Form 10-Q. Accordingly, the condensed consolidated financial statements are unaudited and do not contain all the information required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) to be included in a full set of financial statements. The unaudited condensed consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;"> has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by GAAP for a complete set of financial statements. The audited consolidated financial statements for our fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on Form 10-K on March 13, 2013 include a summary of our significant accounting policies and should be read in conjunction with this Form 10-Q. In the opinion of management, all material adjustments necessary to present fairly the results of operations, cash flows and balance sheets for such periods have been included in this Form 10-Q. All such adjustments are of a normal recurring nature. In addition certain reclassifications have been made to the prior period financial statements to conform to the current period presentation. The results of operations for interim periods are not necessarily indicative of the results of operations for the entire year.</font></div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-342000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2789000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2213000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3515000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1139000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1564000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3035000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-616000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2159000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-891000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
4587000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
4425000 USD
us-gaap Operating Expenses
OperatingExpenses
9651000 USD
us-gaap Operating Expenses
OperatingExpenses
9541000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-632000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3041000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2188000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-906000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2199000 USD
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1985000 USD
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
596000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
642000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
61000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-39000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-19000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-42000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-58000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-58000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-42000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
176000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
295000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3034000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
597000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4887000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4679000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
505000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
396000 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
255000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
282000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2971000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1715000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
53000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
326000 USD
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
203000 USD
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26484000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25994000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4469000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4693000 USD
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
9377000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
18000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
46000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
37000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1047000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
177000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1943000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
996000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
244000 USD
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
244000 USD
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
610000 USD
CY2012Q2 us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
1614000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
CY2013Q2 us-gaap Restructuring Reserve
RestructuringReserve
681000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121153000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118118000 USD
CY2012Q2 us-gaap Revenues
Revenues
12710000 USD
us-gaap Revenues
Revenues
24436000 USD
CY2013Q2 us-gaap Revenues
Revenues
12890000 USD
us-gaap Revenues
Revenues
25680000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3333000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7014000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6022000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3415000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
18414000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
18666000 USD
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
9475000 USD
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1009000 USD
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1671000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3387000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2245000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
327000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
226000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
36449000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
30829000 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2334400 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1073641 shares
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
5121000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2086000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1500000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1200000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19278000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19032000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19315000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19177000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19278000 shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19315000 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19032000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19177000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19177000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19278000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19032000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19315000 shares
digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
CY2013Q2 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
CY2012Q2 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
dei Entity Central Index Key
EntityCentralIndexKey
0000707388
dei Amendment Flag
AmendmentFlag
false
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18098970 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
DIGIRAD CORP
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0000707388-13-000039-index-headers.html Edgar Link pending
0000707388-13-000039-index.html Edgar Link pending
0000707388-13-000039.txt Edgar Link pending
0000707388-13-000039-xbrl.zip Edgar Link pending
digirad-20130630.xml Edgar Link completed
digirad-20130630.xsd Edgar Link pending
digirad-20130630_cal.xml Edgar Link unprocessable
digirad-20130630_def.xml Edgar Link unprocessable
digirad-20130630_lab.xml Edgar Link unprocessable
digirad-20130630_pre.xml Edgar Link unprocessable
drad-6302013x10q.htm Edgar Link pending
drad-6302013xex311.htm Edgar Link pending
drad-6302013xex312.htm Edgar Link pending
drad-6302013xex321.htm Edgar Link pending
drad-6302013xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending